| |
| |
|
| Insider
Information: |
Scheller Richard H |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
381,640 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,916,677 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
381,640 |
|
|
| Total
Value |
$1,916,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
19
|
|
Stock
price went up :
|
0
|
11
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.4
|
| Percentage
Gain/Loss : |
0.0%
|
 -157.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenon Pharmaceuticals Inc. |
XENE |
Director |
2017-08-10 |
7,000 |
2017-08-10 |
0 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
Director |
2023-02-16 |
53,822 |
2019-07-01 |
0 |
Premium* |
|
|
Alector, Inc. |
ALEC |
|
2023-07-15 |
44,250 |
2020-02-04 |
0 |
Premium* |
|
|
Oric Pharmaceuticals, Inc. |
ORIC |
Director |
2021-05-24 |
39,092 |
|
0 |
Premium* |
|
|
Dice Therapeutics, Inc. |
DICE |
Director |
2023-08-09 |
0 |
|
0 |
Premium* |
|
|
23andMe Holding Co. |
ME |
Director |
2023-09-06 |
237,476 |
2021-09-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
45 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2017-08-10 |
4 |
B |
$2.85 |
$19,950 |
D/D |
7,000 |
7,000 |
2.39 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
163,427 |
163,427 |
0 |
- |
|
| ALEC |
Alector, Inc. |
Director |
– • – |
2020-02-04 |
4 |
AS |
$29.67 |
$296,700 |
D/D |
(10,000) |
9,981 |
0 |
% |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2020-04-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2020-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
50,000 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2020-09-16 |
4 |
AS |
$37.50 |
$937,500 |
D/D |
(25,000) |
138,427 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2020-12-15 |
4 |
OE |
$17.00 |
$497,709 |
D/D |
29,277 |
167,704 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2020-12-15 |
4 |
S |
$59.81 |
$1,898,417 |
D/D |
(31,443) |
136,261 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2020-12-18 |
4 |
S |
$64.99 |
$1,952,021 |
D/D |
(30,000) |
106,261 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2020-12-21 |
4 |
S |
$64.81 |
$3,945,137 |
D/D |
(60,401) |
45,860 |
0 |
% |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-04-28 |
4 |
AS |
$25.11 |
$5,022 |
D/D |
(200) |
49,600 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-04-30 |
4 |
AS |
$25.19 |
$2,519 |
D/D |
(100) |
49,500 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-05-11 |
4 |
AS |
$25.16 |
$7,548 |
D/D |
(300) |
49,200 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-05-12 |
4 |
AS |
$25.00 |
$2,575 |
D/D |
(103) |
49,097 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-05-13 |
4 |
AS |
$25.00 |
$2,500 |
D/D |
(100) |
48,997 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-05-14 |
4 |
AS |
$25.38 |
$117,117 |
D/D |
(4,615) |
44,382 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-05-17 |
4 |
AS |
$25.06 |
$12,530 |
D/D |
(500) |
43,882 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-05-18 |
4 |
AS |
$25.34 |
$70,958 |
D/D |
(2,800) |
41,082 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-05-20 |
4 |
AS |
$25.08 |
$16,528 |
D/D |
(659) |
40,423 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-05-21 |
4 |
AS |
$25.19 |
$31,008 |
D/D |
(1,231) |
39,192 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-05-24 |
4 |
AS |
$25.00 |
$2,500 |
D/D |
(100) |
39,092 |
0 |
- |
|
| ALEC |
Alector, Inc. |
Director |
– • – |
2021-07-02 |
4 |
AS |
$31.14 |
$310,808 |
D/D |
(9,981) |
0 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2021-08-04 |
4 |
OE |
$17.00 |
$234,209 |
D/D |
13,777 |
59,637 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2021-08-04 |
4 |
S |
$53.23 |
$733,317 |
D/D |
(13,777) |
45,860 |
0 |
% |
|
| ALEC |
Alector, Inc. |
Director |
– • – |
2021-08-05 |
4 |
AS |
$27.64 |
$1,557,341 |
D/D |
(56,260) |
0 |
0 |
% |
|
45 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
